Close Menu

NEW YORK – 10x Genomics has countersued Bio-Rad Laboratories in a US District Court patent infringement suit.

Last week, 10x responded to Bio-Rad's allegations that 10x's Next GEM microfluidic chips infringe US Patent No. 10,190,115, "Methods and compositions for nucleic acid analysis" which covers the partitioning of a sample into droplets, in some cases.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nearly 30,000 COVID-19 tests the UK sent to the US came back as void, according to the Telegraph.

Black principal investigators receive less favorable application scores when seeking US National Institutes of Health grants, the Chronicle of Higher Education reports.

New Scientist reports that both RNA and DNA may have been involved in the emergence of life on Earth.

In Nature this week: new Sperm-seq method enables crossover analysis, tumor-informed detection approach for minimal residual disease, and more.